AU2001295601A1 - N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists - Google Patents
N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonistsInfo
- Publication number
- AU2001295601A1 AU2001295601A1 AU2001295601A AU9560101A AU2001295601A1 AU 2001295601 A1 AU2001295601 A1 AU 2001295601A1 AU 2001295601 A AU2001295601 A AU 2001295601A AU 9560101 A AU9560101 A AU 9560101A AU 2001295601 A1 AU2001295601 A1 AU 2001295601A1
- Authority
- AU
- Australia
- Prior art keywords
- sub
- sup
- alkyl
- img
- character
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Compounds of formula (I) in free or salt form, where Ar<SUP>1 </SUP>is phenyl substituted by one or more substituents selected from halogen, cyano, nitro, and C<SUB>1</SUB>-C<SUB>8</SUB>-alkyl optionally substituted by cyano or halogen, Ar<SUP>2 </SUP>is phenyl optionally which is unsubstituted or substituted by one or more substituents selected from halogen, cyano, hydroxy, nitro, C<SUB>1</SUB>-C<SUB>8</SUB>-alkyl, C<SUB>1</SUB>-C<SUB>8</SUB>-haloalkyl, C<SUB>1</SUB>-C<SUB>8</SUB>-alkoxy or C<SUB>1</SUB>-C<SUB>8</SUB>-alkoxycarbonyl, R<SUP>1 </SUP>is C<SUB>1</SUB>-C<SUB>8</SUB>-alkyl substituted by hydroxy, C<SUB>1</SUB>-C<SUB>8</SUB>-alkoxy, acyloxy, -N(R<SUP>2</SUP>)R<SUP>3</SUP>, halogen, carboxy, C<SUB>1</SUB>-C<SUB>8</SUB>-alkoxycarbonyl, phenyl-C<SUB>1</SUB>-C<SUB>8</SUB>-alkoxycarbonyl, -CON(R<SUP>4</SUP>)R<SUP>5 </SUP>or by a monovalent cyclic organic group, R<SUP>2 </SUP>and R?3 <img id="CUSTOM-CHARACTER-00001" he="2.12mm" wi="1.44mm" file="US07034042-20060425-P00001.TIF" alt="custom character" img-content="character" img-format="tif"/> are each independently hydrogen or C<SUB>1</SUB>-C<SUB>8</SUB>-alkyl, or R<SUP>2 </SUP>is hydrogen and R<SUP>3 </SUP>is acyl or SO<SUB>2</SUB>R<SUP>6</SUP>, or R<SUP>2 </SUP>and R<SUP>3 </SUP>together with the nitrogen atom to which they are attached denote a 5- or 6-membered heterocyclic group, R<SUP>4 </SUP>and R<SUP>5 </SUP>are each independently hydrogen, C<SUB>1</SUB>-C<SUB>8</SUB>-alkyl optionally substituted by hydroxy or phenyl, or phenyl optionally substituted by C<SUB>1</SUB>-C<SUB>8</SUB>-alkyl, halogen, cyano or C<SUB>1</SUB>-C<SUB>8</SUB>-alkoxy, or R<SUP>4 </SUP>and R<SUP>5 </SUP>together with the nitrogen atom to which they are attached denote a 5- or 6-membered heterocyclic group, R?6 <img id="CUSTOM-CHARACTER-00002" he="2.12mm" wi="1.44mm" file="US07034042-20060425-P00002.TIF" alt="custom character" img-content="character" img-format="tif"/> is C<SUB>1</SUB>-C<SUB>8</SUB>-alkyl, C<SUB>1</SUB>-C<SUB>8</SUB>-haloalkyl, or phenyl optionally substituted by C<SUB>1</SUB>-C<SUB>8</SUB>-alkyl, and n is 1, 2, 3 or 4. The compounds are useful as pharmaceuticals.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0024675A GB0024675D0 (en) | 2000-10-09 | 2000-10-09 | Organic compounds |
GB0024675 | 2000-10-09 | ||
GB0120549 | 2001-08-23 | ||
GB0120549A GB0120549D0 (en) | 2001-08-23 | 2001-08-23 | Organic compounds |
PCT/EP2001/011627 WO2002030898A1 (en) | 2000-10-09 | 2001-10-08 | N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001295601A1 true AU2001295601A1 (en) | 2002-04-22 |
Family
ID=26245127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001295601A Abandoned AU2001295601A1 (en) | 2000-10-09 | 2001-10-08 | N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists |
Country Status (12)
Country | Link |
---|---|
US (1) | US7034042B2 (en) |
EP (1) | EP1330436B1 (en) |
JP (1) | JP4199539B2 (en) |
CN (1) | CN1209351C (en) |
AT (1) | ATE472533T1 (en) |
AU (1) | AU2001295601A1 (en) |
BR (1) | BR0114485A (en) |
CA (1) | CA2423296C (en) |
DE (1) | DE60142484D1 (en) |
ES (1) | ES2348290T3 (en) |
PT (1) | PT1330436E (en) |
WO (1) | WO2002030898A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0117387D0 (en) * | 2001-07-17 | 2001-09-05 | Novartis Ag | Organic compounds |
CN100360521C (en) * | 2002-04-25 | 2008-01-09 | 帝人株式会社 | 4,4-disubstituted piperidine derivatives having CCR3 antagonism |
CN101312965B (en) * | 2005-11-24 | 2011-07-20 | 卫材R&D管理有限公司 | Morpholine type cinnamide compound |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4673684A (en) | 1984-04-04 | 1987-06-16 | Terumo Corporation | Amide derivatives and 5-lipoxygenase inhibitors containing the same as an active ingredient |
JPH0660160B2 (en) * | 1985-12-13 | 1994-08-10 | テルモ株式会社 | Amide derivative and antiallergic agent containing the same |
JPS63139124A (en) * | 1986-12-01 | 1988-06-10 | Terumo Corp | Remedy for nephritis |
JPS63179869A (en) * | 1987-01-20 | 1988-07-23 | Dainippon Pharmaceut Co Ltd | Piperidine derivative |
DE19756235A1 (en) * | 1997-12-17 | 1999-07-01 | Klinge Co Chem Pharm Fab | New piperidinyl-substituted pyridylalkane alkene and alkane carboxylic acid amides |
SK11822001A3 (en) | 1999-03-26 | 2002-09-10 | Astrazeneca Ab | Chemokine activity modulators, method for the preparation thereof, pharmaceutical compositions comprising the same and their use in therapy |
TWI227231B (en) * | 2000-07-12 | 2005-02-01 | Novartis Ag | 4-benzoyl-piperidine derivatives for treating conditions mediated by CCR-3 |
-
2001
- 2001-10-08 DE DE60142484T patent/DE60142484D1/en not_active Expired - Lifetime
- 2001-10-08 AU AU2001295601A patent/AU2001295601A1/en not_active Abandoned
- 2001-10-08 EP EP01976285A patent/EP1330436B1/en not_active Expired - Lifetime
- 2001-10-08 ES ES01976285T patent/ES2348290T3/en not_active Expired - Lifetime
- 2001-10-08 JP JP2002534284A patent/JP4199539B2/en not_active Expired - Fee Related
- 2001-10-08 WO PCT/EP2001/011627 patent/WO2002030898A1/en active Application Filing
- 2001-10-08 US US10/398,533 patent/US7034042B2/en not_active Expired - Fee Related
- 2001-10-08 AT AT01976285T patent/ATE472533T1/en active
- 2001-10-08 BR BR0114485-5A patent/BR0114485A/en not_active IP Right Cessation
- 2001-10-08 PT PT01976285T patent/PT1330436E/en unknown
- 2001-10-08 CN CNB018171028A patent/CN1209351C/en not_active Expired - Fee Related
- 2001-10-08 CA CA002423296A patent/CA2423296C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2423296A1 (en) | 2002-04-18 |
CN1209351C (en) | 2005-07-06 |
WO2002030898A1 (en) | 2002-04-18 |
BR0114485A (en) | 2003-11-18 |
EP1330436A1 (en) | 2003-07-30 |
US20040087621A1 (en) | 2004-05-06 |
DE60142484D1 (en) | 2010-08-12 |
PT1330436E (en) | 2010-10-11 |
ATE472533T1 (en) | 2010-07-15 |
EP1330436B1 (en) | 2010-06-30 |
ES2348290T3 (en) | 2010-12-02 |
JP2004511467A (en) | 2004-04-15 |
CN1468222A (en) | 2004-01-14 |
US7034042B2 (en) | 2006-04-25 |
JP4199539B2 (en) | 2008-12-17 |
CA2423296C (en) | 2009-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200716528A (en) | Cyclopropanecarboxamide derivatives | |
HUP0401478A2 (en) | Pyrazolycarboxanilides as fungicides | |
HUP0102360A2 (en) | 1,3-oxazoline and 1,3-thiazoline derivatives, method for producing the same and their use as pesticides | |
MY119238A (en) | 8-quinolinzanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors | |
EP1775289A4 (en) | Novel imidazolidine derivatives | |
MXPA02003792A (en) | Pyrazole derivatives which modulate human serotonin receptors. | |
MY126139A (en) | Piperidine compounds for use as ccr-3 inhibitors | |
ATE29255T1 (en) | SUCCINIMID DERIVATIVES AND THEIR PREPARATION. | |
BRPI0506927A (en) | organic compounds | |
DE602004009200D1 (en) | TETRAHYDROCHINAZOLINE DERIVATIVES AS CFR ANTAGONISTS | |
TW200744589A (en) | Pharmaceutical composition | |
AU2003250471A8 (en) | Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors | |
DE69401584T2 (en) | BETA, BETA-DIMETHYL-4-PIPERIDINETHANAMINE DERIVATIVES AS INHIBITORS OF THE CHOLESTERIN BIOSYNTHESIS | |
ATE34976T1 (en) | ARYLCYCLOBUTYLALKYLAMINES AND THEIR USE AS ANTIDEPRESSIVE DRUGS. | |
SE0302573D0 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
WO2002000638A3 (en) | Substituted phthalides as anti-convulsive drugs | |
CA2302943A1 (en) | Phthalazine compounds and therapeutic agents for erectile dysfunction | |
AU2001295601A1 (en) | N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists | |
HRP20010630B1 (en) | 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists | |
ATE170851T1 (en) | GUANIDINOTHIAZOLE DERIVATIVES AND THEIR USE AS H2 RECEPTOR ANTAGONISTS | |
KR960014107A (en) | Pyrimidinyl Acrylic Acid Derivatives | |
SE0301445D0 (en) | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof | |
ATE318265T1 (en) | AMIDINE DERIVATIVES, THEIR PRODUCTION AND USE AS MEDICATIONS | |
ATE497497T1 (en) | 1,2,4-TRIAZOLE DERIVATIVE, METHOD FOR THE PRODUCTION THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | |
ATE374751T1 (en) | 3,4-DIHYDRO-1H-QUINOLINE-2-ONE DERIVATIVES AS NOREPINEPHRINE RUPUP INHIBITORS |